Effect of short-acting b--blockers on heart rate and blood pressure in patients with acute coronary syndrome during percutaneous and coronary intervention
Background. The use of b- blockers in acute coronary syndrome (ACS) is recommended for all patients, who has not contraindications. The study of the effects of esmolol during percutaneous coronary intervention (PCI) remains relevant. Objective. To evaluate the features of the effect of esmolol (Bi...
Guardado en:
Autores principales: | L Rasputina, D Didenko, A Solomonchyk |
---|---|
Formato: | article |
Lenguaje: | RU UK |
Publicado: |
Interdisciplinary Academy of Pain Medicine
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0857c04c582a4b7e9186516c1905979e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Differences of patients’ perceptions for elective diagnostic coronary angiography and percutaneous coronary intervention in stable coronary artery disease between elderly and younger patients
por: Rittger H, et al.
Publicado: (2018) -
Chest pain after percutaneous coronary intervention in patients with stable angina
por: Chang CC, et al.
Publicado: (2016) -
Incidence, risk factors and prognostic impact of acute kidney injury after coronary angiography and intervention in kidney transplant recipients: a single-center retrospective analysis
por: Jeannine Lang, et al.
Publicado: (2020) -
High Incidence of Cataracts in the Follow-Up of Patients Undergoing Percutaneous Coronary Intervention for Chronic Coronary Total Occlusion
por: Ricardo Rivera-López, et al.
Publicado: (2021) -
Acute coronary syndrome in octogenarians: association between percutaneous coronary intervention and long-term mortality
por: Barywani SB, et al.
Publicado: (2015)